A PhaseII Study of JTE-052 Ointment in Pediatric Patients with Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Delgocitinib (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 15 Feb 2018 Status changed from active, no longer recruiting to completed.
- 08 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 29 May 2017 New trial record